Citations

Showing 10 of 108094 citations.

Growth hormone deficiency and NAFLD: An overlooked and underrecognized link
Doycheva, Iliana , Erickson, Dana , Watt, Kymberly D.

Mayo Clinic

Hepatology Communications | June 29, 2022 | Volume: 6 | Issue: 9 | Pages: 2227-2237

10.1002/hep4.1953 | PMID 35765700 Get It

Abstract Growth hormone and its mediator insulin‐like growth factor‐1 exert their effect on different organs and control various physiologic metabolic processes. Adult growth hormone deficiency (AGHD) presents with one or more components of metabolic syndrome and can be associated with nonalcoholic fatty liver disease (NAFLD). AGHD is present in spectrum of hypothalamic/pituitary disorders as well as cranial radiation of brain tumors and often remains underdiagnosed or untreated due to its nonspecific symptoms, relatively difficult diagnosis in some clinical scenarios, and various barriers to treatment. NAFLD usually develops soon after diagnosis of AGHD and might progress rapidly to nonalcoholic steatohepatitis (NASH) with advanced fibrosis, eventually requiring liver transplantation. A timely initiation of growth hormone replacement therapy might be important, although studies so far have demonstrated controversial results on NAFLD, primarily due to small sample size and different diagnostic methods of NAFLD. Increased awareness of the association between AGHD and NAFLD would facilitate early diagnosis of NAFLD and NASH if present. Therefore, a multidisciplinary approach involving hepatology and endocrinology should become a standard of care for these patients.
Status of Cardiovascular Health in US Adults and Children Using the American Heart Association’s New “Life’s Essential 8” Metrics: Prevalence Estimates From the National Health and Nutrition Examination Survey (NHANES), 2013 Through 2018
Lloyd‐Jones, Donald M. , Labarthe, Darwin R. , Brewer, LaPrincess C. , Sharma, Garima , Rosamond, Wayne D. , Foraker, Randi E. , Black, Terrie , Anderson, Cheryl A.M. , Brewer, LaPrincess C , Sharma, Garima , Rosamond, Wayne , Foraker, Randi , Anderson, Cheryl , Lloyd-Jones, Donald M , Ning, Hongyan , Grandner, Michael A. , Allen, Norrina B. , Lavretsky, Helen , Perak, Amanda Marma

Mayo Clinic

Circulation | June 29, 2022 | Volume: 146 | Issue: 11 | Pages: 822-835

10.1161/circulationaha.122.060911 | PMID 35766033 Get It

Background: The American Heart Association recently published an updated algorithm for quantifying cardiovascular health (CVH)—the Life’s Essential 8 score. We quantified US levels of CVH using the new score. Methods: We included individuals ages 2 through 79 years (not pregnant or institutionalized) who were free of cardiovascular disease from the National Health and Nutrition Examination Surveys in 2013 through 2018. For all participants, we calculated the overall CVH score (range, 0 [lowest] to 100 [highest]), as well as the score for each component of diet, physical activity, nicotine exposure, sleep duration, body mass index, blood lipids, blood glucose, and blood pressure, using published American Heart Association definitions. Sample weights and design were incorporated in calculating prevalence estimates and standard errors using standard survey procedures. CVH scores were assessed across strata of age, sex, race and ethnicity, family income, and depression. Results: There were 23 409 participants, representing 201 728 000 adults and 74 435 000 children. The overall mean CVH score was 64.7 (95% CI, 63.9–65.6) among adults using all 8 metrics and 65.5 (95% CI, 64.4–66.6) for the 3 metrics available (diet, physical activity, and body mass index) among children and adolescents ages 2 through 19 years. For adults, there were significant differences in mean overall CVH scores by sex (women, 67.0; men, 62.5), age (range of mean values, 62.2–68.7), and racial and ethnic group (range, 59.7–68.5). Mean scores were lowest for diet, physical activity, and body mass index metrics. There were large differences in mean scores across demographic groups for diet (range, 23.8–47.7), nicotine exposure (range, 63.1–85.0), blood glucose (range, 65.7–88.1), and blood pressure (range, 49.5–84.0). In children, diet scores were low (mean 40.6) and were progressively lower in higher age groups (from 61.1 at ages 2 through 5 to 28.5 at ages 12 through 19); large differences were also noted in mean physical activity (range, 63.1–88.3) and body mass index (range, 74.4–89.4) scores by sociodemographic group. Conclusions: The new Life’s Essential 8 score helps identify large group and individual differences in CVH. Overall CVH in the US population remains well below optimal levels and there are both broad and targeted opportunities to monitor, preserve, and improve CVH across the life course in individuals and the population.
Health Impairments in Children and Adolescents After Hospitalization for Acute COVID-19 or MIS-C
Berbert, Laura , Young, Cameron C. , Feldstein, Leora R. , Zambrano, Laura D. , Kücükak, Suden, Newhams, Margaret M. , Miller, Kristen , FitzGerald, Madyson M., He, Jie , Halasa, Natasha , Loftis, Laura L. , Walker, Tracie C. , Gertz, Shira J. , Tarquinio, Keiko M. , Fitzgerald, Julie C. , Kong, Michele , Schuster, Jennifer E. , Mack, Elizabeth H. , Rowan, Courtney M. , Staat, Mary Allen , Zinter, Matt S. , Irby, Katherine , Crandall, Hillary , Flori, Heidi R. , Cullimore, Melissa L. , Nofziger, Ryan A. , Gaspers, Mary Glas , Hume, Janet R. , Levy, Emily R. , Chen, Sabrina , Patel, Manish M. , Weller, Edie, Campbell, Angela P. , Randolph, Adrienne G. , Investigators, for the Overcoming COVID-19, Martin, Lora , Malloch, Lacy , Levy, Emily R , Young, Cameron C , Randolph, Adrienne G , Kong, Michele , Hume, Janet R , Staat, Mary A , Gertz, Shira J , Maddux, Aline B. , Miller, Kristen R. , Cvijanovich, Natalie Z , Schwartz, Stephanie P. , Hobbs, Charlotte V. , Shein, Steven L. , Tenforde, Mark W. , Investigators, for the Overcoming COVID-19

Mayo Clinic

Pediatrics | June 29, 2022 | Volume: 150 | Issue: 3 | Pages: No page available

10.1542/peds.2022-057798 | PMID 35765138 Get It

OBJECTIVES To evaluate risk factors for postdischarge sequelae in children and adolescents hospitalized for acute coronavirus disease 2019 (COVID-19) or multisystem inflammatory syndrome in children (MIS-C). METHODS Multicenter prospective cohort study conducted in 25 United States pediatric hospitals. Patients <21-years-old, hospitalized May 2020 to May 2021 for acute COVID-19 or MIS-C with follow-up 2 to 4 months after admission. We assessed readmissions, persistent symptoms or activity impairment, and new morbidities. Multivariable regression was used to calculate adjusted risk ratios (aRR) and 95% confidence intervals (CI). RESULTS Of 358 eligible patients, 2 to 4 month survey data were available for 119 of 155 (76.8%) with acute COVID-19 and 160 of 203 (78.8%) with MIS-C. Thirteen (11%) patients with acute COVID-19 and 12 (8%) with MIS-C had a readmission. Thirty-two (26.9%) patients with acute COVID-19 had persistent symptoms (22.7%) or activity impairment (14.3%) and 48 (30.0%) with MIS-C had persistent symptoms (20.0%) or activity impairment (21.3%). For patients with acute COVID-19, persistent symptoms (aRR, 1.29 [95% CI, 1.04–1.59]) and activity impairment (aRR, 1.37 [95% CI, 1.06–1.78]) were associated with more organ systems involved. Patients with MIS-C and pre-existing respiratory conditions more frequently had persistent symptoms (aRR, 3.09 [95% CI, 1.55–6.14]) and those with obesity more frequently had activity impairment (aRR, 2.52 [95% CI, 1.35–4.69]). New morbidities were infrequent (9% COVID-19, 1% MIS-C). CONCLUSIONS Over 1 in 4 children hospitalized with acute COVID-19 or MIS-C experienced persistent symptoms or activity impairment for at least 2 months. Patients with MIS-C and respiratory conditions or obesity are at higher risk of prolonged recovery.
Safe Heart Flush Technique During Recovery From Donors After Circulatory Death
Ahmed, Magdy M. El‐Sayed , Landolfo, Kevin, Jacob, Samuel , Sareyyüpoğlu, Başar , Thomas, Mathew , Makey, Ian A. , Landolfo, Kevin , Pham, Si M.

Mayo Clinic

No container title available | June 29, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.165648258.81499266/v1 Get It

For donation after circulatory death, procurement is performed after the heart has arrested. This technique has been employed and adopted by clinicians to overcome the shortage of available hearts for transplant. Warm ischemia time plays a pivotal role in the survival outcome of the heart recipients. We describe a fast and safe technique to flush the heart during recovery from circulatory death donors in order to shorten the warm ischemia time.
The Multistage Antimalarial Compound Calxinin Perturbates P. falciparum Ca2+ Homeostasis by Targeting a Unique Ion Channel
Gupta, Yash , Sharma, Neha , Singh, Snigdha , Romero, Jesús G., Rajendran, Vinoth , Mogire, Reagan M. , Kashif, Mohammad , Jeske, Walter , Poonam, Poonam , Ogutu, Bernhards , Kanzok, Stefan M. , Akala, Hoseah M. , Legac, Jennifer, Rosenthal, Philip J., Rademacher, David J., Durvasula, Ravi , Singh, Agam Prasad , Rathi, Brijesh , Kempaiah, Prakasha , Poonam , Akala, Hoseah M , Singh, Agam P , Rathi, Brijesh , Kempaiah, Prakasha , Gupta, Yash , Beach, Jordan R. , Rosenthal, Philip Jon

Mayo Clinic

Pharmaceutics | June 29, 2022 | Volume: 14 | Issue: 7 | Pages: 1371

10.3390/pharmaceutics14071371 | PMID 35890267 Get It

Malaria elimination urgently needs novel antimalarial therapies that transcend resistance, toxicity, and high costs. Our multicentric international collaborative team focuses on developing multistage antimalarials that exhibit novel mechanisms of action. Here, we describe the design, synthesis, and evaluation of a novel multistage antimalarial compound, ‘Calxinin’. A compound that consists of hydroxyethylamine (HEA) and trifluoromethyl-benzyl-piperazine. Calxinin exhibits potent inhibitory activity in the nanomolar range against the asexual blood stages of drug-sensitive (3D7), multidrug-resistant (Dd2), artemisinin-resistant (IPC4912), and fresh Kenyan field isolated Plasmodium falciparum strains. Calxinin treatment resulted in diminished maturation of parasite sexual precursor cells (gametocytes) accompanied by distorted parasite morphology. Further, in vitro liver-stage testing with a mouse model showed reduced parasite load at an IC50 of 79 nM. A single dose (10 mg/kg) of Calxinin resulted in a 30% reduction in parasitemia in mice infected with a chloroquine-resistant strain of the rodent parasite P. berghei. The ex vivo ookinete inhibitory concentration within mosquito gut IC50 was 150 nM. Cellular in vitro toxicity assays in the primary and immortalized human cell lines did not show cytotoxicity. A computational protein target identification pipeline identified a putative P. falciparum membrane protein (Pf3D7_1313500) involved in parasite calcium (Ca2+) homeostasis as a potential Calxinin target. This highly conserved protein is related to the family of transient receptor potential cation channels (TRP-ML). Target validation experiments showed that exposure of parasitized RBCs (pRBCs) to Calxinin induces a rapid release of intracellular Ca2+ from pRBCs; leaving de-calcinated parasites trapped in RBCs. Overall, we demonstrated that Calxinin is a promising antimalarial lead compound with a novel mechanism of action and with potential therapeutic, prophylactic, and transmission-blocking properties against parasites resistant to current antimalarials.
Attitudes and Behaviors of Physical Activity in Children with Cerebral Palsy: Findings from PLAY Questionnaire
Sugimoto, Dai , Rabatin, Amy E. , Shea, Jodie E., Parmeter, Becky, Shore, Benjamin J. , Stracciolini, Andrea , Shea, Jodie

Mayo Clinic

Children | June 29, 2022 | Volume: 9 | Issue: 7 | Pages: 968

10.3390/children9070968 | PMID 35883952 Get It

To investigate the domains of physical activity in children with cerebral palsy (CP) and to compare these findings to typically developed (TD) children. Methods: A cross-sectional study design. Responses of the four domains in Play Lifestyle and Activity in Youth (PLAY) questionnaire were descriptively analyzed and compared between children with CP (GMFCS I-II) and TD children. Results: Fifty-three children with CP (N = 53, 36 males and 17 females, age of 8.4 ± 1.7 years) and 58 TD children (N = 58, 34 males and 24 females, age of 7.6 ± 1.4 years) participated in this study. In analyses of daily behavior, reported participation in weekly (adaptive) physical education (PE) and sports were more frequent in children with CP (0.6 ± 0.5 days per week) compared to TD children (0.4 ± 0.6 days per week, p = 0.040). Outside play time including free play, organized (adaptive) sports and recess were higher in children with CP (2.7 ± 0.8 days per week) than TD children (2.4 ± 0.7 days per week, p = 0.022). About motivation/attitudes, a higher proportion of TD children feel sad if they are not able to play sports during the day (74.1%) compared to children with CP (48.7%, p < 0.001). Conclusion: Physical activity level was comparable between children with CP and age-matched TD children, while TD children showed higher scores in knowledge and understanding, motivation/attitudes, and physical competence.
Hepatocellular carcinoma downstaging for liver transplantation in the era of systemic combined therapy with anti‐VEGF/TKI and immunotherapy
Muñoz, Sergio , Hallemeier, Christopher L. , Bruix, Jordi , Thompson, Scott, Bruix, Jordi , Tran, Nguyen H. , Thompson, Scott M. , Hallemeier, Christopher Leigh

Mayo Clinic

Hepatology | June 29, 2022 | Volume: 76 | Issue: 4 | Pages: 1203-1218

10.1002/hep.32613 | PMID 35765265 Get It

Abstract Hepatocellular carcinoma remains a global health challenge affecting close to 1 million cases yearly. Liver transplantation provides the best long‐term outcomes for those meeting strict criteria. Efforts have been made to expand these criteria, whereas others have attempted downstaging approaches. Although locoregional approaches to downstaging are appealing and have demonstrated efficacy, limitations and challenges exists including poor imaging modality to assess response and appropriate endpoints along the process. Recent advances in systemic treatments including immune checkpoint inhibitors alone or in combination with tyrosine kinase inhibitors have prompted the discussion regarding their role for downstaging disease prior to transplantation. Here, we provide a review of prior locoregional approaches for downstaging, new systemic agents and their role for downstaging, and finally, key and critical considerations of the assessment, endpoints, and optimal designs in clinical trials to address this key question.
Factors associated with cancer treatment delay: a protocol for a systematic review and meta-analysis
Morrill, Kristin E. , Robles‐Morales, Rogelio , Lopez‐Pentecost, Melissa , Portilla, Raigam J Martínez, Skiba, Meghan B. , Riall, Taylor S. , Austin, Jessica D. , Hirschey, Rachel , Jacobs, Elizabeth T. , Spotleson, Lena, Skiba, Meghan B , Austin, Jessica D , Hanna, Timothy P , Portilla, Raigam Jafet Martínez , Saleh, Ahlam A.

Mayo Clinic

BMJ Open | June 29, 2022 | Volume: 12 | Issue: 6 | Pages: e061121

10.1136/bmjopen-2022-061121 | PMID 35768104 Get It

Introduction Treatment delays are significantly associated with increased mortality risk among adult cancer patients; however, factors associated with these delays have not been robustly evaluated. This review and meta-analysis will evaluate factors associated with treatment delays among patients with five common cancers. Methods and analysis Scientific databases including Ovid MEDLINE, Elsevier Embase, EBSCOhost CINAHL Plus Full Text, Elsevier Scopus and ProQuest Dissertations and Theses Global will be searched to identify relevant articles published between January 2000 and October 2021. Research articles published in the USA evaluating factors associated with treatment delay among breast, lung, prostate, cervical or colorectal adult cancer patients will be included. The primary outcome of the meta-analysis will be the pooled adjusted and unadjusted odds of treatment delay for patient, disease, provider and system-level factors defined according to specified time intervals. The secondary outcomes will be mean or median treatment delay for each cancer site according to first treatment and the influence of factors on the pooled mean treatment delay for each cancer site (via meta-regression analyses). Results from qualitative and mixed-methods studies will be narratively synthesised. Three reviewers will independently screen records generated from the search and two reviewers will independently extract data following a consensus agreement. Statistical heterogeneity will be assessed with a standard I 2 test and funnel plots will be conducted to evaluate publication bias. Risk of bias will be assessed independently by two authors using validated tools according to the article’s study design. Ethics and dissemination Formal ethical approval is not required because the work is being carried out on publicly accessible studies. The findings of this review will be disseminated through a peer-reviewed scientific journal, academic conferences, social media, and key stakeholders. PROSPERO registration number CRD42021293131.
Gender Differences and the Influence of Body Composition on Land and Pool-Based Assessments of Anaerobic Power and Capacity
Zera, Jacquelyn N., Nagle, Elizabeth F., Connell, Emma, Curtin, Erin, Marget, Wilmina M., Simonson, Anna Peluso , Abt, John P. , Lephart, Scott M., Marget, Wilmina , Connell, Emma, Nagai, Takashi

Mayo Clinic

International Journal of Environmental Research and Public Health | June 28, 2022 | Volume: 19 | Issue: 13 | Pages: 7902

10.3390/ijerph19137902 | PMID 35805561 Get It

Consistent differences between males and females have been shown in land-based measurements of anaerobic power and capacity. However, these differences have not been investigated for a tethered 30-s maximal swimming test (TST). The purpose of this study is to explore gender differences in land and pool-based assessments of anaerobic power (Fpeak) and capacity (Fmean), as well as the influence of body composition. Thirteen males and fifteen females completed land (Wingate (WAnT)) and pool-based (TST) measures of anaerobic power and capacity previously described in the literature. Additionally, the subjects completed assessments of body composition via air displacement plethysmography. The males produced higher force than the females for Fpeak (p < 0.001) and Fmean (p = 0.008) during the TST. However, linear regression analysis determined that lean mass significantly predicted Fpeak (p = 0.002) and Fmean (p < 0.001) during the TST, while gender was no longer significant (p = 0.694 and p = 0.136, respectively). In conclusion, increases in anaerobic power and capacity (Fpeak and Fmean) may be a function of increased lean mass in males and females, warranting future research on the impact of resistance training programs on force production and swimming performance.
Improving the Telemedicine Evaluation of Patients With Acute Vision Loss
English, Stephen , Barrett, Kevin M. , Freeman, William D. , Demaerschalk, Bart M. , Dumitrașcu, Oana , English, Stephen W , Dumitrascu, Oana M , Freeman, William D , Demaerschalk, Bart M

Mayo Clinic

Neurology | June 28, 2022 | Volume: 99 | Issue: 9 | Pages: 381-386

10.1212/wnl.0000000000200969 | PMID 35764399 Get It